PharmaSGP Holding SE (PSG) — Capital Reinvestment Ratio
Latest as of March 2025:
0.17x
PharmaSGP Holding SE (PSG) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (€4.22 Million) in capital expenditures (€708.00K). See PSG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
€4.22 Million
EUR
Capital Expenditures
€708.00K
EUR
Data as of
Mar 2025
Most recent filing
PharmaSGP Holding SE Capital Reinvestment Ratio (2014–2024)
This chart tracks PharmaSGP Holding SE's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for PharmaSGP Holding SE (2014–2024)
Year-by-year Capital Reinvestment Ratio for PharmaSGP Holding SE from 2014 to 2024. For live market cap and broader valuation context, see PharmaSGP Holding SE market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.03x | €26.64 Million | €866.00K | ▲ +569.5% |
| 2022 | 0.00x | €24.71 Million | €120.00K | ▼ -36.8% |
| 2021 | 0.01x | €12.24 Million | €94.00K | ▼ -71.7% |
| 2020 | 0.03x | €15.46 Million | €420.00K | ▲ +14.1% |
| 2019 | 0.02x | €17.63 Million | €420.00K | ▼ -26.7% |
| 2018 | 0.03x | €8.43 Million | €274.00K | ▲ +16.7% |
| 2017 | 0.03x | €14.25 Million | €397.00K | ▼ -99.2% |
| 2016 | 3.35x | €3.55 Million | €11.88 Million | ▲ +731.2% |
| 2015 | 0.40x | €10.59 Million | €4.26 Million | ▲ +8.4% |
| 2014 | 0.37x | €5.41 Million | €2.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow